Misplaced Pages

This is an old revision of this page, as edited by Beetstra (talk | contribs) at 21:34, 8 August 2011 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEBI').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Felbinac

Clinical data
Routes of administration	Topical
ATC code	M02AA08 (WHO)
Legal status
Legal status	UK: P (Pharmacy medicines)
Identifiers
IUPAC name biphenyl-4-ylacetic acid
CAS Number	5728-52-9
PubChem CID	3332
DrugBank	DB07477
ChemSpider	3215
UNII	94WNJ5U8L7
KEGG	D01675
ChEBI	CHEBI:31597
ChEMBL	ChEMBL413965
CompTox Dashboard (EPA)	DTXSID0045389
ECHA InfoCard	100.024.758
Chemical and physical data
Formula	C14H12O2
Molar mass	212.244 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES O=C(O)Cc1ccc(cc1)c2ccccc2
InChI InChI=1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16) Key:QRZAKQDHEVVFRX-UHFFFAOYSA-N
(what is this?)  (verify)

Felbinac (INN) (or biphenylylacetic acid) is a topical medicine, belonging to the family of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs) of the arylpropionic acid class, which is used to treat muscle inflammation and arthritis. It is an active metabolite of fenbufen.

Footnotes

1. Kohler C, Tolman E, Wooding W, Ellenbogen L. (1980). "A review of the effects of fenbufen and a metabolite, biphenylacetic acid, on platelet biochemistry and function". Arzneimittelforschung. 30 (4A): 702–707. PMID 6254545.{{cite journal}}: CS1 maint: multiple names: authors list (link)

References

• The Merck Index, 12th Edition. 3989
• Description of Felbinac on Tiscali

This medical article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Medicine stubs
• Non-steroidal anti-inflammatory drugs